0001567619-20-010908.txt : 20200521 0001567619-20-010908.hdr.sgml : 20200521 20200521163430 ACCESSION NUMBER: 0001567619-20-010908 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200519 FILED AS OF DATE: 20200521 DATE AS OF CHANGE: 20200521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hartman Thomas E CENTRAL INDEX KEY: 0001466989 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 20902334 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE, SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0306 4 2020-05-19 0 0000722723 HANGER, INC. HNGR 0001466989 Hartman Thomas E 10910 DOMAIN DRIVE SUITE 300 AUSTIN TX 78758 0 1 0 0 SVP and General Counsel Common Stock 2020-05-19 4 A 0 43641 0 A 120308 D Common Stock 2020-05-19 4 F 0 17173 17.12 D 103135 D Stock Options (right to buy) 12.77 2027-05-19 Common Stock 70818 70818 D Shares received pursuant to the Company's Special Equity Plan as a result of the vesting of PSUs awarded in 2017 due to the achievement of predetermined levels of absolute common stock price compounded annual growth period over the three-year performance period. Reflects payment of tax liability by withholding shares of stock incident to vesting of performance shares. Consists of (i) unvested restricted shares totaling 7,973 shares of stock from an initial grant of 7,973 shares of restricted stock that begins to vest on March 9, 2021 (ii) unvested restricted shares and fully vested shares totaling 6,949 shares of stock from an initial grant of 7,708 shares of restricted stock made on March 8, 2019 (iii) unvested restricted shares and fully vested shares totaling 8,235 shares of stock from an initial grant of 9,134 shares of restricted stock made on March 8, 2019; (iv) unvested restricted shares and fully vested shares totaling 7,166 shares of stock from an initial grant of 8,868 shares of restricted stock made on March 9, 2018; (v) unvested restricted shares and fully vested shares totaling 7,846 shares of stock from an initial grant of 10,500 shares of restricted stock, the remainder of which will vest on March 8, 2020 and 2021; [continued in next footnote] (vi) unvested restricted shares and fully vested shares totaling 9,009 shares of stock from an initial grant of 11,147 shares of restricted stock made on March 9, 2018; (vii) fully vested shares totaling 4,363 shares of stock from an initial grant of 6,359 shares of restricted stock made on March 6, 2015; (viii) unvested restricted shares and fully vested shares totaling 7,473 shares of stock from an initial grant of 10,000 shares of restricted stock made on March 8, 2017; (ix) unvested restricted shares and fully vested shares totaling 3,886 shares of stock from an initial grant of 5,000 shares of restricted stock made on October 11, 2016; [continued in next footnote] (x) unvested restricted shares and fully vested shares totaling 4,980 shares of stock from an initial grant of 10,000 shares of restricted stock made on April 29, 2016; (xi) fully vested shares totaling 3,513 shares of stock from an initial grant of 4,958 shares of restricted stock made on November 10, 2015; (xii) fully vested shares totaling 2,432 shares of stock from an initial grant of 4,239 shares of restricted stock made on March 6, 2015; (xiii) fully vested shares totaling 764 shares of stock from an initial grant of 1,731 shares of restricted stock made on March 7, 2014; (xiv) fully vested shares totaling 878 shares of stock from an initial grant of 3,246 shares of restricted stock and performance made on March 11, 2013; [continued in next footnote] and (xv) fully vested shares totaling 1,200 shares from an initial grant of 4,800 shares of restricted stock made on March 7, 2012. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Thomas E. Hartman 2020-05-21